A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma.
Saulnier Sholler GL, Bergendahl GM, Brard L, Singh AP, Heath BW, Bingham PM, Ashikaga T, Kamen BA, Homans AC, Slavik MA, Lenox SR, Higgins TJ, Ferguson WS.
Saulnier Sholler GL, et al. Among authors: singh ap.
J Pediatr Hematol Oncol. 2011 Jan;33(1):25-30. doi: 10.1097/MPH.0b013e3181f47061.
J Pediatr Hematol Oncol. 2011.
PMID: 21063221
Clinical Trial.